pamidronate has been researched along with Muscle Disorders in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug." | 5.10 | A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. ( Aaron, SL; Chiu, P; Davis, P; Fitzgerald, AA; Homik, J; Jhangri, GS; LeClercq, S; Maksymowych, WP; Russell, AS; Sholter, D; Skeith, KJ; Yan, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maksymowych, WP | 1 |
| Jhangri, GS | 1 |
| Fitzgerald, AA | 1 |
| LeClercq, S | 1 |
| Chiu, P | 1 |
| Yan, A | 1 |
| Skeith, KJ | 1 |
| Aaron, SL | 1 |
| Homik, J | 1 |
| Davis, P | 1 |
| Sholter, D | 1 |
| Russell, AS | 1 |
1 trial available for pamidronate and Muscle Disorders
| Article | Year |
|---|---|
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diphosphonates | 2002 |